Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
22.08
-2.67 (-10.79%)
May 7, 2026, 10:35 AM EDT - Market open
Castle Biosciences Market Cap
Castle Biosciences has a market cap or net worth of $668.93 million as of May 7, 2026. Its market cap has increased by 5.51% in one year.
Market Cap
668.93M
Enterprise Value
524.86M
1-Year Change
5.51%
Ranking
Category
Stock Price
$22.08
Market Cap Chart
Since July 25, 2019, Castle Biosciences's market cap has increased from $123.05M to $668.93M, an increase of 443.62%. That is a compound annual growth rate of 28.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 749.83M | -33.96% |
| Dec 31, 2025 | 1.14B | 52.12% |
| Dec 31, 2024 | 746.39M | 28.53% |
| Dec 29, 2023 | 580.73M | -6.38% |
| Dec 30, 2022 | 620.32M | -43.76% |
| Dec 31, 2021 | 1.10B | -32.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GRAIL | 2.69B |
| Adaptive Biotechnologies | 2.31B |
| NeoGenomics | 1.16B |
| CareDx | 1.08B |
| GeneDx Holdings | 1.03B |
| OPKO Health | 845.70M |
| Personalis | 635.39M |
| Fulgent Genetics | 423.74M |